Health and Healthcare

Myriad Genetics : MYGN

All Myriad Genetics Articles

85 Articles

Lee Jackson | Apr 9, 2015 at 9:45 AM EDT

Cowen Thinks 3 Life Science Stocks Can Beat Earnings Estimates

In a new research report, Cowen analysts focus on three life science stocks that they think could beat current consensus…

Jon C. Ogg | Mar 26, 2015 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Apple, ASML, Schwab, GoPro, Kraft, Netflix, Red Hat and More

Thursday's top analyst upgrades and downgrades include Apple, ASML, Charles Schwab, GoPro, Kraft Foods, Netflix and Red Hat.

Jon C. Ogg | Mar 10, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AcelRx, AECOM, EA, HP, Myriad, Urban Outfitters and More

Tuesday's top analyst upgrades and downgrades include AcelRx Pharmaceuticals, AECOM, Electronic Arts, Hewlett-Packard, Myriad Genetics and Urban Outfitters.

Paul Ausick | Feb 4, 2015 at 11:10 AM EST

Just How Bad Have Things Gotten at Myriad Genetics?

Myriad Genetics shares traded down as much as 16% Wednesday morning after the company lowered its fiscal-year guidance.

Jon C. Ogg | Feb 4, 2015 at 8:15 AM EST

Top Analyst Upgrades and Downgrades: Coupons.com, Dean Foods, Hilton, Isis Pharma, NOV, Stratasys and More

Wednesday's top analyst upgrades, downgrades and initiations include Coupons.com, Dean Foods, Hilton, Isis Pharma, National Oilwell Varco and Stratasys.

Lee Jackson | Nov 11, 2014 at 9:10 AM EST

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation…

Jon C. Ogg | Nov 10, 2014 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: BioMarin, BP, Genworth, Petrobras, Target and More

Monday's top analyst upgrades, downgrades and initiations include BioMarin Pharmaceutical, BP, Home Depot, Petrobras and Target.

Lee Jackson | Nov 4, 2014 at 9:55 AM EST

Earnings Surprises Could Hammer Short Sellers of These 4 Stocks

A new research note from Cantor Fitzgerald profiles stocks with upcoming earnings reports and huge short interest. These four stocks…

Jon C. Ogg | Aug 12, 2014 at 5:18 PM EDT

Top After-Hours Stocks on the Move for Tuesday

Thinkstock24/7 Wall St. has tracked several hot stocks on the move in Tuesday’s after-hours trading session. Most of the news…

Jon C. Ogg | Feb 7, 2014 at 8:30 AM EST

Top Analyst Upgrades and Downgrades: AOL, Echelon, Fairway Group, LinkedIn, Lululemon, More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on is Friday, February 7,…

Jon C. Ogg | Feb 5, 2014 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Arch Coal, ADM, Citigroup, Myriad, Sirius and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, February 5, 2014.…

Jon C. Ogg | Dec 30, 2013 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Gilead, Teva, Textura, Twitter and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, December 30, 2013.

Jon C. Ogg | Oct 21, 2013 at 8:25 AM EDT

Top Analyst Downgrades, Stocks to Sell: Ariad, Goodyear, Myriad, Kellogg and More

Jon OggStocks are at all-time highs now that a deal has been reached in Washington, D.C., and investors have to…

Paul Ausick | Jun 14, 2013 at 4:04 PM EDT

Closing Bell for Friday on Wall Street: Markets Open Lower, Trail South All Day

U.S. equity markets opened lower this morning, kicking off a gradual decline that lasted all day. Profit-taking and a lower-than-expected…

Jon C. Ogg | Jun 14, 2013 at 8:10 AM EDT

Top 10 Analyst Upgrades and Downgrades: ADP, GameStop, Myriad, SolarCity and More

Jon OggInvestors and traders are frequently looking for fresh research ideas that will generate higher income or more profits. 24/7…

1 2 3 4 5 6

Myriad Genetics : MYGN

All Myriad Genetics Articles

Cowen Thinks 3 Life Science Stocks Can Beat Earnings Estimates

Top Analyst Upgrades and Downgrades: Apple, ASML, Schwab, GoPro, Kraft, Netflix, Red Hat and More

Top Analyst Upgrades and Downgrades: AcelRx, AECOM, EA, HP, Myriad, Urban Outfitters and More

Just How Bad Have Things Gotten at Myriad Genetics?

Top Analyst Upgrades and Downgrades: Coupons.com, Dean Foods, Hilton, Isis Pharma, NOV, Stratasys and More

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

Top Analyst Upgrades and Downgrades: BioMarin, BP, Genworth, Petrobras, Target and More

Earnings Surprises Could Hammer Short Sellers of These 4 Stocks

Top After-Hours Stocks on the Move for Tuesday

Top Analyst Upgrades and Downgrades: AOL, Echelon, Fairway Group, LinkedIn, Lululemon, More

Top Analyst Upgrades and Downgrades: Arch Coal, ADM, Citigroup, Myriad, Sirius and More

Top Analyst Upgrades and Downgrades: Gilead, Teva, Textura, Twitter and More

Top Analyst Downgrades, Stocks to Sell: Ariad, Goodyear, Myriad, Kellogg and More

Closing Bell for Friday on Wall Street: Markets Open Lower, Trail South All Day

Top 10 Analyst Upgrades and Downgrades: ADP, GameStop, Myriad, SolarCity and More

Can This Texas Couple Survive on One Income While She Chases a Writing Dream?

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Can This Texas Couple Survive on One Income While She Chases a Writing Dream?

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Can This Texas Couple Survive on One Income While She Chases a Writing Dream?

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

Myriad Genetics : MYGN

All Myriad Genetics Articles

Cowen Thinks 3 Life Science Stocks Can Beat Earnings Estimates

Top Analyst Upgrades and Downgrades: Apple, ASML, Schwab, GoPro, Kraft, Netflix, Red Hat and More

Top Analyst Upgrades and Downgrades: AcelRx, AECOM, EA, HP, Myriad, Urban Outfitters and More

Just How Bad Have Things Gotten at Myriad Genetics?

Top Analyst Upgrades and Downgrades: Coupons.com, Dean Foods, Hilton, Isis Pharma, NOV, Stratasys and More

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

Top Analyst Upgrades and Downgrades: BioMarin, BP, Genworth, Petrobras, Target and More

Earnings Surprises Could Hammer Short Sellers of These 4 Stocks

Top After-Hours Stocks on the Move for Tuesday

Top Analyst Upgrades and Downgrades: AOL, Echelon, Fairway Group, LinkedIn, Lululemon, More

Top Analyst Upgrades and Downgrades: Arch Coal, ADM, Citigroup, Myriad, Sirius and More

Top Analyst Upgrades and Downgrades: Gilead, Teva, Textura, Twitter and More

Top Analyst Downgrades, Stocks to Sell: Ariad, Goodyear, Myriad, Kellogg and More

Closing Bell for Friday on Wall Street: Markets Open Lower, Trail South All Day

Top 10 Analyst Upgrades and Downgrades: ADP, GameStop, Myriad, SolarCity and More

Can This Texas Couple Survive on One Income While She Chases a Writing Dream?

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Featured Reads

Can This Texas Couple Survive on One Income While She Chases a Writing Dream?

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make